Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Akshay Bhamidipati"'
OmicNavigator: open-source software for the exploration, visualization, and archival of omic studies
Autor:
Terrence R. Ernst, John D. Blischak, Paul Nordlund, Joe Dalen, Justin Moore, Akshay Bhamidipati, Pankaj Dwivedi, Joe LoGrasso, Marco Rocha Curado, Brett Warren Engelmann
Publikováno v:
BMC Bioinformatics, Vol 25, Iss 1, Pp 1-10 (2024)
Abstract Background The results of high-throughput biology (‘omic’) experiments provide insight into biological mechanisms but can be challenging to explore, archive and share. The scale of these challenges continues to grow as omic research volu
Externí odkaz:
https://doaj.org/article/da5c781ee7424b5d975e1ed6e5bb02cd
Autor:
Jeffrey W. Chen, Aaron Yengo-Kahn, Silky Chotai, Akshay Bhamidipati, Candice Smith, Philip Davis, Rebecca A. Reynolds, Mary Peyton Boyd, Tyler W. Barrett, Elizabeth S. Compton, Bradley M. Dennis, Michael S. Norris, Mayur B. Patel, Jacob P. Schwarz, Nicholas R. Thomason, Reid C. Thompson, Oscar D. Guillamondegui
Publikováno v:
Injury. 54:82-86
Patients with mild traumatic brain injury (TBI) and intracranial hemorrhage often receive neurosurgical consultation. However, only a small proportion of patients require intervention. Our hypothesis is that low-risk minimal TBI patients managed with
Publikováno v:
Neurosurgery Clinics of North America. 34:167-174
The purpose of this article was to consider, evaluate, and compare the clinical outcomes measurement tools that are used to assess patients with Chiari I malformation. This article highlights the variety of general and disease-specific outcome measur
Autor:
Bhupesh Mangla, Ank A. Agarwal, Karan Patel Bs Bs, Shravika Lam, Basil M Baccouche, Cassandra J Liew, Akshay Bhamidipati, Ria Soni, Anjali Mangla, Tatum R Dam Dam, Medha Illindala
Publikováno v:
Journal of Neurology Research Reviews & Reports. :1-6
Schizophrenia is a psychiatric condition characterized by dysfunction in thoughts, behavior, and emotions. The illness is typically diagnosed in late adolescence to early adulthood, and generally lasts throughout a patient’s lifetime. This debilita
Autor:
Jin-Yih Low, Minjeong Ko, Brian Hanratty, Radhika A. Patel, Akshay Bhamidipati, Christopher M. Heaphy, Erolcan Sayar, John K. Lee, Shan Li, Angelo M. De Marzo, William G. Nelson, Anuj Gupta, Srinivasan Yegnasubramanian, Gavin Ha, Jonathan I. Epstein, Michael C. Haffner
Publikováno v:
The American journal of pathology. 193(1)
Basal cell carcinoma (BCC) of the prostate is a rare tumor. Compared with the more common acinar adenocarcinoma (AAC) of the prostate, BCCs show features of basal cell differentiation and are thought to be biologically distinct from AAC. The spectrum
Autor:
Julie DiNitto, Michael Feldman, Heather Grimaudo, Nishit Mummareddy, Seoiyoung Ahn, Akshay Bhamidipati, Drew Anderson, Juan Carlos Ramirez-Giraldo, Matthew Fusco, Rohan Chitale, Michael T Froehler
Publikováno v:
Interventional Neuroradiology. :159101992311574
Background Management of large vessel occlusion (LVO) patients after thrombectomy is affected by the presence of intracranial hemorrhage (ICH) on post-procedure imaging. Differentiating contrast staining from hemorrhage on post-procedural imaging has
Autor:
David M. Esopi, Nicole Castagna, Ruedi Aebersold, Radhika A. Patel, Angelo M. De Marzo, Tiannan Guo, Gunes Guner, Harrison Tsai, Michael C. Haffner, Jessica Hicks, Ajay Vaghasia, William G. Nelson, Nicolas Wyhs, Jin-Yih Low, Minh-Tam Pham, Srinivasan Yegnasubramanian, Akshay Bhamidipati
Publikováno v:
The Prostate, 81 (15)
Prostate
Prostate
Background Resistance to androgen deprivation therapies is a major driver of mortality in advanced prostate cancer. Therefore, there is a need to develop new preclinical models that allow the investigation of resistance mechanisms and the assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e2ea4aa79165fe7e890ad85bb58beed2
https://hdl.handle.net/20.500.11850/501735
https://hdl.handle.net/20.500.11850/501735
Autor:
Angelo M. De Marzo, Radhika A. Patel, Gunes Guner, Harrison Tsai, Minh-Tam Pham, Ruedi Aebersold, Tiannan Guo, Akshay Bhamidipati, David M. Esopi, Jessica Hicks, Ajay Vaghasia, Michael C. Haffner, Nicolas Wyhs, Jin-Yih Low, Nicole Castagna, Srinivasan Yegnasubramanian, William G. Nelson
BACKGROUNDResistance to androgen deprivation therapies is a major driver of mortality in advanced prostate cancer. Therefore, there is a need to develop new pre-clinical models that allow the investigation of resistance mechanisms and the assessment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16685d7af4fcbe84d72fcf445bd5999a
https://doi.org/10.1101/2021.07.04.450352
https://doi.org/10.1101/2021.07.04.450352
Publikováno v:
Journal of Clinical Oncology. 40:e17037-e17037
e17037 Background: The poly(ADP-ribose) polymerase inhibitors (PARPi) olaparib and rucaparib have been approved for the treatment of metastatic castration resistant prostate cancer (mCRPC) in the setting of homologous recombination deficiency (HRD).
Publikováno v:
Cureus
In order to prescribe an antibiotic, a physician must go through a series of decision-making processes that involve both the drug and the host. In this review article, we outline exactly what those decision-making processes are and some of their limi